Anthropic’s public filing puts a proposed Nasdaq IPO under the ticker ANT in motion, but it does not settle when shares will trade or at what price. Reports point to a possible debut in the week of November 16, while the price range and number of shares remain undisclosed. Investors should also distinguish direct shares from funds targeting daily returns and from tokenized exposure.
6
9
31
What’s confirmed about the proposed ANT IPO
Anthropic filed a registration statement for an initial public offering of Class A common stock on October 26, 2026. The company said it intends to list on the Nasdaq Global Select Market under the symbol ANT. Its filing said the share count and price range had not yet been determined.
6
A November 2 filing update was reported as adding a retail-investor distribution plan. Anthropic expects a portion of the IPO shares to be offered through six brokerage firms: Charles Schwab, Fidelity, Robinhood, SoFi, Morgan Stanley’s E*TRADE and TradePMR. That is a plan for distribution, not a guarantee that every eligible customer will receive shares; the available reports do not specify the number reserved for retail investors.
38
47
The date and price are still uncertain
The week of November 16 has been reported as a potential target for the debut, but Anthropic has not announced a first trading date. The initial filing left the price range and share count open, and reporting on the IPO continues to describe those terms as unset.
6
9
31
The reported target is not a launch commitment. Before the stock can begin trading, the company and underwriters still need to complete the offering process, set a price and have the registration statement become effective.
10
49
ProShares’ proposed ANTU and ANTY ETFs
ProShares announced plans to offer two Anthropic-linked ETFs after the IPO: ANTU, targeting twice the stock’s daily performance before fees and expenses, and ANTY, targeting negative twice its daily performance. The funds are intended to offer leveraged bullish or inverse bearish exposure—not ordinary ownership of Anthropic shares. Their registration statements have been filed but are not yet effective, so the proposed funds may change.
16
19
The daily target matters. A fund seeking a multiple of a stock’s daily return does not promise the same multiple of its return over a longer holding period: daily changes compound. Investors considering either fund should therefore assess its daily objective and risks rather than treating “2x” or “−2x” as a long-term forecast.
16
The proposed Anthropic funds fit into ProShares’ broader single-stock ETF lineup, which has included products tied to companies such as Nvidia, Tesla and Palantir.
24
Kraken’s reported tokenized offer is a different product
Reports describe Kraken’s proposed xStocks product as a way for eligible customers to request tokenized exposure linked to Anthropic’s IPO price. The reported offer includes a 5% spread: if applied to a $1,000 request, that would amount to $50. The arithmetic illustrates the reported fee; it does not independently verify the product’s final terms.
2
37
A tokenized product is not the same as receiving Anthropic Class A shares. Reports say a request may be filled in full, in part or not at all, so access and allocation should not be assumed.
32
37
The practical distinction
The proposed IPO, ETFs and token offer provide different kinds of exposure. ANT would represent Anthropic’s publicly listed Class A stock if and when the offering proceeds. ANTU and ANTY would seek leveraged or inverse daily returns. Kraken’s reported product is tokenized exposure, with reported terms that include a spread and an uncertain allocation.
6
16
19
37
For now, the clearest takeaway is that the filing and planned ticker are public, but the IPO’s price, share count and trading date are not. Related products may offer other ways to take a view on Anthropic, but their terms, availability and risks are distinct from owning ANT shares.